ChEMBL1044

GPTKB entity

Statements (29)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:approvedBy true
gptkbp:ATCCode gptkb:C07AB03
gptkbp:Bioavailability 50%
gptkbp:CASNumber gptkb:29122-68-7
gptkbp:drugClass beta blocker
gptkbp:hasInChIKey METKIMKYRPQLGS-UHFFFAOYSA-N
gptkbp:hasMolecularFormula C14H22N2O3
gptkbp:hasSMILES CC(C)NCC(CO)Oc1ccc(cc1)CC(=O)N
https://www.w3.org/2000/01/rdf-schema#label ChEMBL1044
gptkbp:indication myocardial infarction
hypertension
angina pectoris
gptkbp:IUPACName 4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenylacetamide
gptkbp:KEGGID gptkb:D00222
gptkbp:mechanismOfAction beta-1 adrenergic receptor antagonist
gptkbp:molecularWeight 266.34
gptkbp:name gptkb:Atenolol
gptkbp:PubChem_CID 2162
CHEBI:2269
DB00335
CHEMBL1044
gptkbp:routeOfAdministration oral
gptkbp:synonym gptkb:Atenololum
gptkb:Tenormin
gptkbp:target beta-1 adrenergic receptor
gptkbp:UNII 50VV3VW0TI
gptkbp:bfsParent gptkb:CBD
gptkbp:bfsLayer 5